Welcome to LookChem.com Sign In|Join Free
  • or
1H-Indazol-5-ol,4-bromois a chemical compound that belongs to the indazole class. It features a five-membered ring with nitrogen and two carbon atoms, a hydroxyl group at the 5th position, and a bromine atom at the 4th position. This unique structure and its properties make it a promising candidate for pharmaceutical applications and medicinal chemistry research.

478838-52-7

Post Buying Request

478838-52-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

478838-52-7 Usage

Uses

Used in Pharmaceutical Industry:
1H-Indazol-5-ol,4-bromois used as a chemical intermediate for the development of new drugs and medications. Its distinctive structure allows it to be a potential candidate in the creation of innovative pharmaceutical compounds that can address various health conditions and diseases. The presence of the hydroxyl and bromine atoms in its molecular structure may contribute to its reactivity and binding properties, which are crucial for drug design and synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 478838-52-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,8,8,3 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 478838-52:
(8*4)+(7*7)+(6*8)+(5*8)+(4*3)+(3*8)+(2*5)+(1*2)=217
217 % 10 = 7
So 478838-52-7 is a valid CAS Registry Number.

478838-52-7Downstream Products

478838-52-7Relevant academic research and scientific papers

KRAS G12D INHIBITORS

-

Paragraph 0950, (2021/03/05)

The present invention relates to compounds that inhibit KRas G12D. In particular, the present invention relates to compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.

HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

-

Page/Page column 105; 106, (2016/12/22)

Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 478838-52-7